Universal Biosensors (UBI) Stock Price, News & Analysis

Company Overview

The Company is a specialist medical diagnostics company focused on the development, manufacture and commercialisation of a range of in vitro diagnostic tests for point-of-care use.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 10,006 shs
• Average Volume: N/A
• Market Capitalization: A$22.36 million
• P/E Ratio: N/A
• Dividend Yield: 8.55%
• Price Target: N/A
• Consensus Rating: N/A

UBI Stock Analysis - Frequently Asked Questions

How were Universal Biosensors' earnings last quarter?

Universal Biosensors, Inc. (ASX:UBI) released its quarterly earnings results on Tuesday, April, 30th. The company reported ($0.01) EPS for the quarter. Universal Biosensors had a negative trailing twelve-month return on equity of 59.40% and a negative net margin of 175.04%.

Company Calendar

• Last Earnings: 4/30/2019
• Today: 7/13/2025

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: ASX:UBI
• CIK: N/A
• Web: www.universalbiosensors.com
• Phone: +61-3-92139000
• Fax: N/A
• Employees: 80
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A($0.05)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$11.58 million
• Net Margins: -175.04%
• Pretax Margin: N/A
• Return on Equity: -59.40%
• Return on Assets: -27.91%

Debt

• Debt-to-Equity Ratio: 16.18
• Current Ratio: 5.03
• Quick Ratio: 2.13

Sales & Book Value

• Annual Sales: A$7.13 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 1.26
• Book Value: A$0.07 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 298,070,000
• Free Float: N/A
• Market Cap: A$22.36 million
• Optionable: Not Optionable
• Beta: 0.93